Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia I Vlaicu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|June 4, 2019
Role of C5b-9 and RGC-32 in CancerSonia I Vlaicu, Alexandru Tatomir, Violeta Rus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2018
Letter by Rus et al Regarding Article, "RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis"Horea Rus, Anamaria Talpos-Caia, Alexandru Tatomir, et al.
Frontiers in Immunology|August 3, 2023
COVID, complement, and the brainSonia I Vlaicu, Alexandru Tatomir, Jacob Cuevas, et al.
Immunologic Research|January 13, 2016
The role of complement system in adipose tissue-related inflammationSonia I Vlaicu, Alexandru Tatomir, Dallas Boodhoo, et al.
Immunologic Research|June 29, 2019
RGC-32 and diseases: the first 20 yearsSonia I Vlaicu, Alexandru Tatomir, Freidrich Anselmo, et al.
Immunologic Research|June 21, 2015
The role of complement activation in atherogenesis: the first 40 yearsSonia I Vlaicu, Alexandru Tatomir, Violeta Rus, et al.
Frontiers in Immunology|April 25, 2020
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in OligodendrocytesAlexandru Tatomir, Gautam Rao, Dallas Boodhoo, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2008
Role of response gene to complement 32 in diseasesSonia I Vlaicu, Cornelia Cudrici, Takahiro Ito, et al.
Clinical Immunology (Orlando, Fla.)|April 24, 2022
RGC-32' dual role in smooth muscle cells and atherogenesisSonia I Vlaicu, Alexandru Tatomir, Matthew Fosbrink, et al.
Immunologic Research|December 19, 2012
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancerSonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|June 4, 2019
Role of C5b-9 and RGC-32 in CancerSonia I Vlaicu, Alexandru Tatomir, Violeta Rus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2018
Letter by Rus et al Regarding Article, "RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis"Horea Rus, Anamaria Talpos-Caia, Alexandru Tatomir, et al.
Frontiers in Immunology|August 3, 2023
COVID, complement, and the brainSonia I Vlaicu, Alexandru Tatomir, Jacob Cuevas, et al.
Immunologic Research|January 13, 2016
The role of complement system in adipose tissue-related inflammationSonia I Vlaicu, Alexandru Tatomir, Dallas Boodhoo, et al.
Immunologic Research|June 29, 2019
RGC-32 and diseases: the first 20 yearsSonia I Vlaicu, Alexandru Tatomir, Freidrich Anselmo, et al.
Immunologic Research|June 21, 2015
The role of complement activation in atherogenesis: the first 40 yearsSonia I Vlaicu, Alexandru Tatomir, Violeta Rus, et al.
Frontiers in Immunology|April 25, 2020
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in OligodendrocytesAlexandru Tatomir, Gautam Rao, Dallas Boodhoo, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2008
Role of response gene to complement 32 in diseasesSonia I Vlaicu, Cornelia Cudrici, Takahiro Ito, et al.
Clinical Immunology (Orlando, Fla.)|April 24, 2022
RGC-32' dual role in smooth muscle cells and atherogenesisSonia I Vlaicu, Alexandru Tatomir, Matthew Fosbrink, et al.
Immunologic Research|December 19, 2012
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancerSonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al.
Pageof 2